Nicholas Hornstein/X
Jan 27, 2025, 18:35
Nicholas Hornstein: Few takeaways from ASCO GI25
Nicholas Hornstein, Assistant Professor of Medical Oncology at Northwell Health, shared a post on X:
“As GI-ASCO comes to a close I think there are a few takeaways.
1. Progress continues to march forward. dMMR disease is increasingly a systemically managed disease with excellent cure fraction (embrace CTLA4)
2. IO is breaking into MSS CRC
3. The undruggable is becoming druggable
4. Aspirin and Celecoxib may have clinical benefit!?
5. ctDNA is here to stay, but we need to identify actionable strategies.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 20:25
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29
Apr 19, 2025, 17:53